Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group. Issue 4 (10th October 2017)

• Record Type: Journal Article
• Authors: Bank, PCD; Caudle, KE; Swen, JJ; Gammal, RS; Whirl‐Carrillo, M; Klein, TE; Relling, MV; Guchelaar, H‐J
• Is Part Of: Clinical pharmacology & therapeutics. Volume 103:Issue 4(2018)
• Page Start: 599
• Page End: 618
• Publication Date: 2017-10-10
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1002/cpt.762
• Languages: English
• ISSNs: 0009-9236

Abstract

Abstract : Both the Clinical Pharmacogenetics Implementation Consortium (CPIC) and Dutch Pharmacogenetics Working Group provide therapeutic recommendations for well‐known gene‐drug pairs. Published recommendations show a high rate of concordance. However, as a result of different guideline development methods used by these two consortia, differences between the published guidelines exist. The aim of this paper is to compare both initiatives and explore these differences, with the objective to achieve harmonization.